Preterm Birth: Clinical Trials

1 trial for Preterm Birth, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Preterm Birth: new trials by email Literature Review of Preterm Birth trials Research Report on Preterm Birth

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth
17-Hydroxyprogesterone caproate 250mg or 500 mg., Safety study of 500 mg dose. - Preterm Birth
Phase 1 / Phase 2TerminatedSteve N. Caritis, MD1592018-02-122023-10-23

Narrower conditions

Premature Birth (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (1)  ·  Obstetric Labor Complications (1)  ·  Obstetric Labor, Premature (1)  ·  Pregnancy Complications (1)  ·  Urogenital Diseases (1)

Interventions

Safety (1)

Sponsors

Steve N. Caritis, MD (1)

Countries

United States (1)

Top investigators

Steve N Caritis, MD (1)

Results publications

PMID 37100349

NIH funding

U54HD047905 (1)